1. Patient‐reported outcomes of a phase II neoadjuvant apalutamide (ARN‐509) and radical prostatectomy in treatment of intermediate‐ to high‐risk prostate cancer (NEAR) trial. (24th August 2022) Authors: Yang, Xinyan; Allen, John Carson; Aslim, Edwin Jonathan; Tay, Kae Jack; Yuen, Shyi Peng John; Kanesvaran, Ravindran; Chua, Melvin Lee Kiang; Chong, Tsung Wen; Ho, Sun Sien Henry; Lee, Lui Shiong Journal: International journal of urology Issue: Volume 29:Number 11(2022) Page Start: 1322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗